Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

Vinay Prasad is once again head of the FDA’s Center for Biologics Evaluation and Research, after Laura Loomer led a campaign ...

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

The public deserves to the full story about Dr. Vinay Prasad's temporary resignation and how this might impact regulatory decisions moving forward.

By Betsy Klein, Meg Tirrell, Sarah Owermohle, Adam Cancryn, CNN (CNN) — Dr. Vinay Prasad, a controversial critic of the US Food and Drug ...

Vinay Prasad, MD, MPH, who was appointed to run the FDA's Center for Biologics Evaluation and Research (CBER) in May, then ...

The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...

Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory agency in May, has resigned less than three months into the job. “Dr. Prasad did ...

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the ...

AstraZeneca's quarterly revenue beat expectations, boosted by its oncology and biopharmaceuticals segments and strong U.S. demand. The Anglo-Swedish pharmaceutical giant said Tuesday that for the ...